Peritoneal Neoplasm — Trials

Peritoneal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

592 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 151–200 of 592 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05200364	A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer	terminated	Phase 1	58	Sutro Biopharma, Inc.INDUSTRY	1	Sep 22, 2025	clinicaltrials
NCT03029403	Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer	active not recruiting	Phase 2	47	University Health Network, TorontoOTHER	1	Sep 19, 2025